103 related articles for article (PubMed ID: 17031801)
1. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers.
Souchelnytskyi S; Lomnytska M; Dubrovska A; Hellman U; Volodko N
Proteomics; 2006 Sep; 6 Suppl 2():65-8. PubMed ID: 17031801
[No Abstract] [Full Text] [Related]
2. Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients.
Lomnytska M; Dubrovska A; Hellman U; Volodko N; Souchelnytskyi S
Int J Cancer; 2006 Jan; 118(2):412-21. PubMed ID: 16049973
[TBL] [Abstract][Full Text] [Related]
3. A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform.
Montazery-Kordy H; Miran-Baygi MH; Moradi MH
J Zhejiang Univ Sci B; 2008 Nov; 9(11):863-70. PubMed ID: 18988305
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
[TBL] [Abstract][Full Text] [Related]
5. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
6. An integrated approach utilizing proteomics and bioinformatics to detect ovarian cancer.
Yu JK; Zheng S; Tang Y; Li L
J Zhejiang Univ Sci B; 2005 Apr; 6(4):227-31. PubMed ID: 15754417
[TBL] [Abstract][Full Text] [Related]
7. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
[TBL] [Abstract][Full Text] [Related]
8. [Identification of a novel serum marker for early breast cancer detection by proteomic approach].
Kadowaki M; Nagashima T; Sakakibara M; Suzuki TH; Miyazaki M
Nihon Rinsho; 2012 Sep; 70 Suppl 7():460-3. PubMed ID: 23350442
[No Abstract] [Full Text] [Related]
9. [Progress in the study of the uses of proteomics in gynecologic oncology].
Yang YS; Chen JL; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):425-7. PubMed ID: 15312333
[No Abstract] [Full Text] [Related]
10. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
[TBL] [Abstract][Full Text] [Related]
11. New screen could 'change the prognosis' for ovarian cancer.
Dis Manag Advis; 2003 Jan; 9(1):1-4. PubMed ID: 12619292
[No Abstract] [Full Text] [Related]
12. [Application of serum proteomics in breast cancer research].
Zhu ZM; Hu XF; Zeng R
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
[No Abstract] [Full Text] [Related]
13. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
Davis MA; Hanash S
Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
[TBL] [Abstract][Full Text] [Related]
14. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
[TBL] [Abstract][Full Text] [Related]
15. Application of proteomics in ovarian cancer: which sample should be used?
Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of proteomics in breast cancer: state of the art and perspectives.
Goncalves A; Bertucci F
Med Princ Pract; 2011; 20(1):4-18. PubMed ID: 21160207
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer: biomarker proteomic diagnosis in progress.
Zhang Y; Guo B; Bi R
Appl Biochem Biotechnol; 2012 Oct; 168(4):910-6. PubMed ID: 22945560
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profile in familial breast cancer patients.
Garrisi VM; Tommasi S; Facchiano A; Bongarzone I; De Bortoli M; Cremona M; Cafagna V; Abbate I; Tufaro A; Quaranta M; Paradiso A
Clin Biochem; 2013 Feb; 46(3):259-65. PubMed ID: 23159292
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
